Cost Effectiveness of Bosentan for Pulmonary Arterial Hypertension: A Systematic Review

Cost Effectiveness of Bosentan for Pulmonary Arterial Hypertension: A Systematic Review

Objectives. Although many studies have reported on the cost-effectiveness of bosentan for treating pulmonary arterial hypertension (PAH), a systematic review of economic evaluations of bosentan is currently lacking. Objective evaluation of current pharmacoeconomic evidence can assist decision makers...

Full description

Saved in:

Bibliographic Details
Main Authors:	Ruxu You, Xinyu Qian, Weijing Tang, Tian Xie, Fang Zeng, Jun Chen, Yu Zhang, Jinyu Liu
Format:	Article
Language:	English
Published:	Wiley 2018-01-01
Series:	Canadian Respiratory Journal
Online Access:	http://dx.doi.org/10.1155/2018/1015239
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effect of bosentan therapy in persistent pulmonary hypertension of the newborn
by: Gunlawadee Maneenil, et al.
Published: (2018-02-01)

THE EFFICIENCY OF BOSENTAN BASED ON THE DATA OF THE REGISTER OF PATIENTS WITH PULMONARY HYPERTENSION IN THE VORONEZH REGION
by: O. M. Korolkova
Published: (2017-06-01)

CLINICAL CASE: COMBINATION THERAPY WITH BOSENTAN AND SILDENAFIL IN THE TREATMENT OF IDIOPATHIC PULMONARY HYPERTENSION
by: V. V. Bystrov, et al.
Published: (2014-12-01)

THE RESULTS OF LONG-TERM PAH-SPECIFIC MONOTHERAPY WITH BOSENTAN IN PATIENTS WITH IDIOPATHIC PULMONARY HYPERTENSION
by: V. M. Paramonov, et al.
Published: (2016-06-01)

CLINICAL CASE OF REPLACEMENT OF ENDOTHELIN RECEPTOR ANTAGONIST (BOSENTAN) BY SOLUBLE GUANYLATE CYCLASE STIMULATOR (RIOCIGUAT) IN THE PATIENT WITH PULMONARY ARTERIAL HYPERTENSION
by: E. A. Devetyarova, et al.
Published: (2018-06-01)

THE EFFECTIVENESS OF COMBINATION THERAPY WITH BOSENTAN AND SILDENAFIL IN PATIENTS WITH THE CLINICAL WORSENING OF IDIOPATHIC PULMONARY HYPERTENSION ON THE BACKGROUND OF SPECIFIC MONOTHERAPY
by: V. M. Paramonov, et al.
Published: (2016-12-01)

Study on the comparison between Bosentan and Macitentan in the treatment of persistent pulmonary hypertension of the newborns, simultaneously on sildenafil: A randomized double-blinded non-inferiority parallel clinical trial
by: Mandana Kashaki, et al.
Published: (2025-01-01)

Successful Treatment with Bosentan of Lower Extremity Ulcers in a Scleroderma Patient
by: Alix Naert, et al.
Published: (2013-01-01)

Cardioprotective Effects of Bosentan in Rats Subjected to Lung Ischemia–Reperfusion Injury
by: Şevki Mustafa Demiröz, et al.
Published: (2025-07-01)

An Atypical Presentation of Liver Enzyme Elevation Resulting from Bosentan Use
by: Kimberley Mulchey, et al.
Published: (2009-01-01)

FIRST EXPERIENCE OF BOSENTAN IN COMPLEX MANAGEMENT OF A CHILD WITH VENA GALENI ANEURYSM
by: I. I. Trunina, et al.
Published: (2017-02-01)

Safety of pericardiocentesis in pulmonary arterial hypertension: a systematic review
by: Maria Jose Cabada-Garcia, et al.
Published: (2025-08-01)

Deciphering the transcriptomic landscape of systemic lupus erythematosus-associated pulmonary arterial hypertension
by: Yutong Li, et al.
Published: (2025-03-01)

The Role and Regulation of Pulmonary Artery Smooth Muscle Cells in Pulmonary Hypertension
by: Shixin He, et al.
Published: (2020-01-01)

Impact of BMPR2 mutation on the severity of pulmonary arterial hypertension: a systematic review and meta-analysis
by: Jixing Wu, et al.
Published: (2025-02-01)

Cost-Effectiveness of Treprostinil Versus Epoprostenol in Patients with Pulmonary Arterial Hypertension: A Canadian Analysis
by: Thomas R Einarson, et al.
Published: (2005-01-01)

Pulmonary arterial hypertension with cardiopulmonary comorbidities: is it a unique phenotype?
by: Meng Zhang, et al.
Published: (2025-07-01)

PULMONARY ARTERIAL HYPERTENSION AND LIVER DISEASE
by: E. Kh. Akhmetzyanova, et al.
Published: (2010-12-01)

Exercise Intolerance in Pulmonary Arterial Hypertension
by: Robin M. Fowler, et al.
Published: (2012-01-01)

Societal Costs Associated With Pulmonary Arterial Hypertension Subgroups: A Study Utilizing Linked National Registries
by: Barbro Kjellström, et al.
Published: (2025-04-01)

Pulmonary Arterial Hypertension Specific Therapy in Patients with Combined Post- and Precapillary Pulmonary Hypertension
by: Hassan Alfraidi, et al.
Published: (2018-01-01)

Prevalence and Economic Burden of Pulmonary Hypertension and Pulmonary Arterial Hypertension Among the Medicaid Population
by: Marshaleen Henriques King, et al.
Published: (2025-04-01)

Pulmonary Artery Dissection: A Fatal Complication of Pulmonary Hypertension
by: Chuanchen Zhang, et al.
Published: (2016-01-01)

Acute Effects of Vardenafil on Pulmonary Artery Responsiveness in Pulmonary Hypertension
by: Edibe Karasu-Minareci, et al.
Published: (2012-01-01)

Pulmonary hypertension associated with anomalous left coronary artery originating from the pulmonary artery
by: Anqi Duan, et al.
Published: (2025-02-01)

Use of combined chemotherapy and immunotherapy improves pulmonary arterial hypertension
by: Tejaswini P. Reddy, et al.
Published: (2024-07-01)

MODERN PHARMACEUTICAL TREATMENT OF PULMONARY ARTERIAL HYPERTENSION
by: D. V. Preobrazhensky, et al.
Published: (2009-12-01)

Heart Rate Variability in Pulmonary Arterial Hypertension
by: Bishal Gyawali, et al.
Published: (2025-01-01)

Pulmonary arterial hypertension: challenges and achievements 2021
by: E. A. Rezukhina, et al.
Published: (2022-03-01)

PULMONARY ARTERIAL HYPERTENSION IN CONNECTIVE TISSUE DISEASES
by: A. V. Volkov
Published: (2015-03-01)

FEATURES OF PULMONARY ARTERIAL HYPERTENSION IN THE RUSSIAN REGISTER
by: O. A. Arkhipova, et al.
Published: (2014-12-01)

Mechanism and prospects of empagliflozin in pulmonary arterial hypertension
by: Xiaofa Chen, et al.
Published: (2025-08-01)

Pregnancy and pulmonary artery hypertension: Management challenges
by: Gurleen Wander, et al.
Published: (2025-03-01)

Iron deficiency in pulmonary arterial hypertension: perspectives
by: Marceau Quatredeniers, et al.
Published: (2021-07-01)

Modern pharmaceutical treatment of pulmonary arterial hypertension
by: T. A. Batyraliev, et al.
Published: (2008-12-01)

Economic burden of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) in Finland
by: Markku Pentikäinen, et al.
Published: (2024-12-01)

Comprehensive proteomic characterization of pulmonary arterial hypertension in Chinese people
by: Tianya Liu, et al.
Published: (2025-08-01)

Assessment of biomechanical properties in pulmonary arterial hypertension: a computational fluid dynamics study of the extensive pulmonary arterial tree
by: Jian Shi, et al.
Published: (2025-04-01)

The Pulmonary Artery Pulsatility Index Provides No Additional Prognostic Information in Pediatric Pulmonary Arterial Hypertension
by: Faye E. Smits, et al.
Published: (2024-09-01)

Long-Term Survival in Idiopathic Pulmonary Arterial Hypertension Associated with Massive Pulmonary Artery Dilation
by: Vanja Petrovic, et al.
Published: (2011-01-01)